Assignee
TARGIMMUNE THERAPEUTICS AG
CH·6 granted patents·9 pending applications·14 citations·filing 2015–2023
Top patents by PatentIndex Score
15 records- 0187US10543232B2Polyplex of double-stranded RNA and polymeric conjugateTARGIMMUNE THERAPEUTICS AG·Filed 2019·Granted Jan 28, 2020·8 cites·23 claims
- 0283US10278991B2Polyethyleneimine polyethyleneglycol vectorsTARGIMMUNE THERAPEUTICS AG·Filed 2015·Granted May 7, 2019·5 cites·25 claims
- 0380US11298376B2Method of treating cancerTARGIMMUNE THERAPEUTICS AG·Filed 2019·Granted Apr 12, 2022·1 cites·30 claims
- 0471US2022339189A1Method of treating cancerTARGIMMUNE THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0567US2024033364A1Castration resistant prostate cancerTARGIMMUNE THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 0665US2026000700A1Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the sameTARGIMMUNE THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 0763US2022213158A1CHIMERIC PROTEINS FOR TARGETING dsRNATARGIMMUNE THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0861US11912747B2Chimeric proteins for targeting dsRNATARGIMMUNE THERAPEUTICS AG·Filed 2016·Granted Feb 27, 2024·0 cites·20 claims
- 0961US11679160B2Castration resistant prostate cancerTARGIMMUNE THERAPEUTICS AG·Filed 2018·Granted Jun 20, 2023·0 cites·20 claims
- 1055US2026000771A1Psma-targeting linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the sameTARGIMMUNE THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 1154US2025135014A1Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the sameTARGIMMUNE THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 1253US11230580B2Chimeric proteins for targeting dsRNATARGIMMUNE THERAPEUTICS AG·Filed 2018·Granted Jan 25, 2022·0 cites·20 claims
- 1348US2023372384A1Immunotherapy for the treatment of cancerTARGIMMUNE THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 1448US2020407453A1A recombinant protein comprising a double stranded rna binding domainTARGIMMUNE THERAPEUTICS AG·Filed 2019·Application pending·0 cites
- 1546US2022175814A1Immunotherapy for the treatment of cancerTARGIMMUNE THERAPEUTICS AG·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TARGIMMUNE THERAPEUTICS AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →